Angiopoietin-like protein 4 (Angpt14) is the second member of the angiopoietin-like family of proteins previously shown to increase plasma triglyceride (TG) levels in vivo. We recently reported that Angpt14 is a variable-sized oligomer formed by intermolecular disulfide bonds and undergoes regulated proteolytic processing upon secretion. We now show that adenoviral overexpression of Angpt14 potently increases plasma TG levels by a mechanism independent of food intake or hepatic VLDL secretion. We determined that cysteine residues at positions 76 and 80 of Angpt14, conserved among mouse, rat, and human, are required to form higher order structures. By generating adenoviral expression vectors of Angpt14 containing different epitope tags at both N and C termini, we show that loss of oligomerization results in decreased stability of the N-terminal coiled-coil domain of Angpt14 as well as decreased ability to increase plasma TG levels, suggesting that intermolecular disulfide bond formation plays important roles in determining the magnitude of the hyperlipidemic effect of Angpt14.jlr Because Angpt14 is more potent than Angpt13 in increasing plasma TG levels in mice, inappropriate oligomerization of Angpt14 could be associated with disorders of lipid metabolism in vivo.